Literature DB >> 25869235

Comparison of Outcomes for Osteochondral Lesions of the Talus With and Without Chronic Lateral Ankle Instability.

Moses Lee1, Ji Won Kwon1, Woo Jin Choi1, Jin Woo Lee2.   

Abstract

BACKGROUND: Previous reports suggest that prolonged instability of the ankle may contribute to development of osteochondral lesions and eventually lead to osteoarthritis. However, no studies have directly compared osteochondral lesions in ankles with chronic lateral ankle instability (CLAI) to those without instability. This study was performed to determine characteristics and resulting clinical outcomes associated with osteochondral lesions of the talus (OLT) in patients with and without instability.
METHODS: Of 420 patients who underwent primary arthroscopic marrow stimulation for OLT, 74 patients were identified as having concomitant CLAI. After considering age, sex, body mass index, and initial trauma history for the propensity score (1:2 ratio), a total of 148 patients without CLAI were matched from the remainder of the cohort. Demographics and lesion characteristics were compared using preoperative magnetic resonance imaging (MRI) and arthroscopy. Clinical outcomes were compared using a visual analog scale (VAS), the American Orthopaedic Foot & Ankle Society (AOFAS) ankle score, and the Foot and Ankle Outcome Score (FAOS).
RESULTS: The OLT group with CLAI presented a significantly increased proportion of lateral-side OLT, large OLT (150 mm(2) or larger), and chondral lesions at the tip of the medial malleolus (P = .018, P = .024, and P < .001, respectively). VAS and AOFAS scores were comparable at the last follow-up. However, the OLT with CLAI group also exhibited a significantly increased proportion of failure (AOFAS score less than 80) and inferior outcomes in the FAOS for the sport and recreation subscale (P = .034 and P = .005, respectively).
CONCLUSIONS: Compared with osteochondral lesions in ankles without CLAI, osteochondral lesions in an unstable ankle had an increased proportion of larger lesions (150 mm(2) or larger) and additional chondral lesions at the tip of the medial malleolus and the tibia plafond. This group also displayed increased clinical failure (AOFAS score less than 80). Inferior performance in sport and recreational activities may be more likely in patients with both OLT and CLAI. LEVEL OF EVIDENCE: Level III, retrospective cohort study.
© The Author(s) 2015.

Entities:  

Keywords:  FAOS; ankle; arthroscopic marrow stimulation; chronic lateral ankle instability; osteochondral lesion

Mesh:

Year:  2015        PMID: 25869235     DOI: 10.1177/1071100715581477

Source DB:  PubMed          Journal:  Foot Ankle Int        ISSN: 1071-1007            Impact factor:   2.827


  20 in total

1.  Large variation in management of talar osteochondral lesions among foot and ankle surgeons: results from an international survey.

Authors:  Matteo Guelfi; Christopher W DiGiovanni; James Calder; Francesc Malagelada; Guillaume Cordier; Masato Takao; Jorge Batista; Caio Nery; Marino Delmi; Miki Dalmau-Pastor; Giovanni Carcuro; Gabriel Khazen; Jordi Vega
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2020-11-22       Impact factor: 4.342

2.  Concurrent arthroscopic osteochondral lesion treatment and lateral ankle ligament repair has no substantial effect on the outcome of chronic lateral ankle instability.

Authors:  Dong Jiang; Yin-Fang Ao; Chen Jiao; Xing Xie; Lin-Xin Chen; Qin-Wei Guo; Yue-Lin Hu
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2017-11-14       Impact factor: 4.342

3.  Treatment of talus osteochondral defects in chronic lateral unstable ankles: small-sized lateral chondral lesions had good clinical outcomes.

Authors:  Hong Li; Yinghui Hua; Hongyun Li; Shengkun Li; Kui Ma; Shiyi Chen
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2017-06-02       Impact factor: 4.342

Review 4.  Arthroscopic one-step matrix-assisted bone marrow stimulation for the treatment of osteochondral defects of the talus.

Authors:  Stephanie Geyer; Jens Mattes; Wolf Petersen; Andreas B Imhoff; Andrea E Achtnich
Journal:  Oper Orthop Traumatol       Date:  2021-10-05       Impact factor: 1.286

Review 5.  Osteochondral Lesions of the Talus: A Review on Talus Osteochondral Injuries, Including Osteochondritis Dissecans.

Authors:  Juergen Bruns; Christian Habermann; Mathias Werner
Journal:  Cartilage       Date:  2021-01-09       Impact factor: 3.117

6.  Preoperative MRI is helpful but not sufficient to detect associated lesions in patients with chronic ankle instability.

Authors:  Kevin Staats; Manuel Sabeti-Aschraf; Sebastian Apprich; Hannes Platzgummer; Stephan E Puchner; Johannes Holinka; Reinhard Windhager; Reinhard Schuh
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2017-05-15       Impact factor: 4.342

Review 7.  Diagnosis and Operation Results for Chronic Lateral Ankle Instability with Subtle Cavovarus Deformity and a Peek-A-Boo Heel Sign.

Authors:  Dong Woo Shim; Jae Wan Suh; Kwang Hwan Park; Jin Woo Lee; Junwoo Byun; Seung Hwan Han
Journal:  Yonsei Med J       Date:  2020-07       Impact factor: 2.759

8.  Incidence of Coexisting Talar and Tibial Osteochondral Lesions Correlates With Patient Age and Lesion Location.

Authors:  Rebecca M Irwin; Yoshiharu Shimozono; Youichi Yasui; Robin Megill; Timothy W Deyer; John G Kennedy
Journal:  Orthop J Sports Med       Date:  2018-08-23

9.  Clinical Guidelines for the Surgical Management of Chronic Lateral Ankle Instability: A Consensus Reached by Systematic Review of the Available Data.

Authors:  Yujie Song; Hongyun Li; Chao Sun; Jian Zhang; Jianchao Gui; Qinwei Guo; Weidong Song; Xiaojun Duan; Xiaoqin Wang; Xuesong Wang; Zhongming Shi; Yinghui Hua; Kanglai Tang; Shiyi Chen
Journal:  Orthop J Sports Med       Date:  2019-09-23

10.  Typical Shape Differences in the Subtalar Joint Bones Between Subjects with Chronic Ankle Instability and Controls.

Authors:  Nazlı Tümer; Gwendolyn Vuurberg; Leendert Blankevoort; Gino M M J Kerkhoffs; Gabrielle J M Tuijthof; Amir A Zadpoor
Journal:  J Orthop Res       Date:  2019-05-26       Impact factor: 3.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.